FindTrial
Sign In

Diagnostic Value of ACTH Stimulation Test under 1mg dexamethasone suppression test in differentiating the Subtypes of Primary Aldosteronism

Diagnostic Value of ACTH Stimulation Test under 1mg dexamethasone suppression test in differentiating the Subtypes of Primary Aldosteronism

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090753
Enrollment
Unknown
Registered
2024-10-12
Start date
2024-10-15
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Aldosteronism

Interventions

Gold Standard:Adrenal CT results, adrenal MRI results, AVS results, postoperative pathology, and treatment response are used for comprehensive assessment and subtyping of AHA and IHA.
Index test:ACTH Stimulation Test under 1mg dexamethasonesuppression test

Sponsors

Department of Endocrinology, the First Medical Center, Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients who meet the diagnostic criteria for PA

Exclusion criteria

Exclusion criteria: Other types of secondary hypertension; resistant hypertension; severe heart failure; and active gastrointestinal bleeding; the ACTH stimulation test is not suitable for patients older than 80 years.

Design outcomes

Primary

MeasureTime frame
Plasma aldosterone concentration;—

Secondary

MeasureTime frame
PAC/synchronous cortisol concentration;—

Countries

China

Contacts

Public ContactGuo Qinghua

Department of Endocrinology, the First Medical Center, Chinese PLA General Hospital

2557230300@qq.com+86 136 9136 7351

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026